DK0630252T3 - Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme - Google Patents

Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme

Info

Publication number: DK0630252T3
Authority: DK; Denmark
Prior art keywords: rhamnolipid; pharmaceutical preparation; dermatological diseases; preparation based; mono
Prior art date: 1992-02-04

Application number

DK93914523T

Other languages

English (en)

Inventor

Goran Piljac

Visnja Piljac

Original Assignee

Paradigm Biomedical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-04

Filing date

1993-02-04

Publication date

2005-04-04

1993-02-04 Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc

2005-04-04 Application granted granted Critical

2005-04-04 Publication of DK0630252T3 publication Critical patent/DK0630252T3/da

Links

FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 title abstract 3
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
229920006395 saturated elastomer Polymers 0.000 abstract 2
125000004417 unsaturated alkyl group Chemical group 0.000 abstract 2
241001123589 Gorilla papillomavirus Species 0.000 abstract 1
208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Virology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Pulmonology (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Birds (AREA)
General Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK93914523T 1992-02-04 1993-02-04 Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme DK0630252T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
BE9200115A BE1005704A4 (nl)	1992-02-04	1992-02-04	Farmaceutisch preparaat op basis van rhamnolipide.
US86669192A	1992-04-10	1992-04-10
PCT/EP1993/000270 WO1993014767A2 (en)	1992-02-04	1993-02-04	Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
EP93914523A EP0630252B1 (en)	1992-02-04	1993-02-04	Pharmaceutical preparation based on rhamnolipid against dermatological diseases

Publications (1)

Publication Number	Publication Date
DK0630252T3 true DK0630252T3 (da)	2005-04-04

Family

ID=25662615

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93914523T DK0630252T3 (da)	1992-02-04	1993-02-04	Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme

Country Status (11)

Country	Link
EP (1)	EP0630252B1 (da)
JP (2)	JP3860206B2 (da)
AT (1)	ATE284697T1 (da)
AU (1)	AU3453493A (da)
BE (1)	BE1005704A4 (da)
CA (1)	CA2129542C (da)
DE (1)	DE69333723T2 (da)
DK (1)	DK0630252T3 (da)
ES (1)	ES2235155T3 (da)
PT (1)	PT630252E (da)
WO (1)	WO1993014767A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5466675A (en) *	1992-02-04	1995-11-14	Piljac; Goran	Immunological activity of rhamnolipids
DE69936635T2 (de) *	1998-02-24	2008-05-08	Paradigm Biomedical, Inc., St. Petersburg	Verwendundung von Rhamnolipiden als Kosmetika
EP1889623A3 (en) *	1998-02-24	2009-04-08	Paradigm Biomedical Inc.	Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
WO2001010447A1 (en) *	1999-08-05	2001-02-15	Tamara Stipcevic	Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
US20040242501A1 (en) *	2003-03-20	2004-12-02	Gross Richard A.	Spermicidal and virucidal properties of various forms of sophorolipids
DE102005052210A1 (de) *	2005-10-26	2007-05-03	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Mikrobiologisch stabilisiertes Bier
WO2008013899A2 (en) *	2006-07-27	2008-01-31	Aurora Advance Beauty Labs	Rhamnolipid-based formulations
US10434058B2 (en)	2010-12-09	2019-10-08	Y&B Mother's Choice Ltd.	Natural formulations
US10064881B2 (en)	2010-12-09	2018-09-04	Y&B Mother's Choice Ltd.	Natural formulations
CA2858505A1 (en)	2010-12-09	2012-06-14	Y&B Mother's Choice Ltd.	Formulations comprising saponins and uses thereof
DE102012221519A1 (de) *	2012-11-26	2014-05-28	Evonik Industries Ag	Verfahren zur Isolierung von Rhamnolipiden
EP2786742A1 (de) *	2013-04-02	2014-10-08	Evonik Industries AG	Kosmetika enthaltend Rhamnolipide
DE102013205756A1 (de) *	2013-04-02	2014-10-02	Evonik Industries Ag	Mischungszusammensetzung enthaltend Rhamnolipide
IL229836A0 (en)	2013-12-08	2014-03-31	Y & B Mother S Choice Ltd	Formulations to reduce or suppress irritation to eye tissue
US20170143771A1 (en) *	2014-06-20	2017-05-25	joint Center for Biosciences	Composition containing pseudomonas aeruginosa culture solution extract having antibiotic and antiseptic activities, and use thereof
EP3338762A1 (en) *	2016-12-22	2018-06-27	L'oreal	Use of rhamnolipids for the cosmetic treatment of skin redness
CN115884755A (zh) *	2020-08-28	2023-03-31	莱雅公司	包含糖脂和水杨酸衍生物的组合物
EP4015588A1 (de) *	2020-12-15	2022-06-22	Evonik Operations GmbH	Verwendung von rhamnolipiden und/oder sophorolipiden in beschichtungszusammensetzungen zur erhaltung eines homogenen farbbildes des trockenen beschichtungsfilms und/oder zur erhöhung der arbeitssicherheit bei der herstellung von beschichtungszusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4814953B1 (da) *	1970-10-14	1973-05-11
JPS60183032A (ja) *	1984-03-02	1985-09-18	Shiseido Co Ltd	乳化組成物
DD248279A1 (de) *	1984-09-07	1987-08-05	Univ Leipzig	Antiphytovirale therapie mit biogenen mitteln
JPS6377533A (ja) *	1986-09-18	1988-04-07	Fujitsu Ltd	減圧処理装置の圧力切り替え方法
JPS63253025A (ja) *	1987-04-09	1988-10-20	Yamanouchi Pharmaceut Co Ltd	ホスホリパ−ゼａ↓２阻害剤
FR2645741B1 (fr) *	1989-03-20	1995-06-23	Dior Christian Parfums	Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation

1992
- 1992-02-04 BE BE9200115A patent/BE1005704A4/nl not_active IP Right Cessation
1993
- 1993-02-04 DK DK93914523T patent/DK0630252T3/da active
- 1993-02-04 ES ES93914523T patent/ES2235155T3/es not_active Expired - Lifetime
- 1993-02-04 AU AU34534/93A patent/AU3453493A/en not_active Abandoned
- 1993-02-04 AT AT93914523T patent/ATE284697T1/de not_active IP Right Cessation
- 1993-02-04 CA CA002129542A patent/CA2129542C/en not_active Expired - Fee Related
- 1993-02-04 JP JP51294693A patent/JP3860206B2/ja not_active Expired - Fee Related
- 1993-02-04 DE DE69333723T patent/DE69333723T2/de not_active Expired - Lifetime
- 1993-02-04 EP EP93914523A patent/EP0630252B1/en not_active Expired - Lifetime
- 1993-02-04 PT PT93914523T patent/PT630252E/pt unknown
- 1993-02-04 WO PCT/EP1993/000270 patent/WO1993014767A2/en not_active Ceased
2004
- 2004-01-05 JP JP2004000631A patent/JP2004149547A/ja active Pending

Also Published As

Publication number	Publication date
DE69333723D1 (de)	2005-01-20
CA2129542C (en)	2008-04-22
CA2129542A1 (en)	1993-08-05
AU3453493A (en)	1993-09-01
JP3860206B2 (ja)	2006-12-20
PT630252E (pt)	2005-04-29
JP2004149547A (ja)	2004-05-27
EP0630252A1 (en)	1994-12-28
WO1993014767A3 (en)	1993-09-02
JPH09503196A (ja)	1997-03-31
BE1005704A4 (nl)	1993-12-21
EP0630252B1 (en)	2004-12-15
ATE284697T1 (de)	2005-01-15
DE69333723T2 (de)	2005-12-08
ES2235155T3 (es)	2005-07-01
WO1993014767A2 (en)	1993-08-05

Publication	Publication Date	Title
DK0630252T3 (da)	2005-04-04	Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
NO950297D0 (no)	1995-01-26	Prolinamidderivater
DE69131317D1 (de)	1999-07-15	HIV-Proteaseinhibitoren
HUP0101999A2 (hu)	2001-11-28	4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
ATE185792T1 (de)	1999-11-15	Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
DE69206876D1 (de)	1996-02-01	Nukleosidanalogen enthaltende Antiviren-Zubereitungen
ES2148254T3 (es)	2000-10-16	Peptidos antimicrobianos ciclicos y preparacion de los mismos.
FI921522A0 (fi)	1992-04-07	Pyrazolopyridinfoerening och foerfarande foer dess framstaellning.
CA2336412A1 (en)	2000-01-13	Medicament for treatment of diabetes
KR890003382A (ko)	1989-04-14	항 비루스성 화합물
MD1560F2 (en)	2000-11-30	Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK132188A (da)	1988-09-13	Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
NZ308398A (en)	1999-06-29	2-amino benzoxazin-4-one derivatives and medicaments
DE68923169D1 (de)	1995-07-27	Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ES2103440T3 (es)	1997-09-16	Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69330601D1 (de)	2001-09-20	Serotoninergische ergolin derivate
MX9206930A (es)	1993-06-01	Nuevos compuestos
BR9305752A (pt)	1997-01-28	Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
DK0420224T3 (da)	1993-04-05	Anthihepatopatisk middel
KR930016417A (ko)	1993-08-26	피롤릴벤조디아제핀온
DK0784973T3 (da)	2002-03-18	Quinoxalinderivater til behandling af tinnitus
DK653687A (da)	1988-06-13	Middel til behandling af nyresygdomme
DE69327077D1 (de)	1999-12-30	Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
DK165967C (da)	1993-07-26	Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
EP0653207A4 (en)	1995-03-06	AIDS VIRUS INFECTIVE COMPOSITION.